Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Transition Therapeutics Inc (NASDAQ:TTHI)

2.15
Delayed Data
As of Sep 03
 -0.0708 / -3.19%
Today’s Change
1.77
Today|||52-Week Range
9.30
-68.57%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close2.22
Today’s open2.28
Day’s range2.09 - 2.28
Volume56,412
Average volume (3 months)220,806
Market cap$86.3M
Dividend yield--
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)-52.28%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc+0.04+0.41%
ERBERBA Diagnostics Inc+0.13+7.65%
CALACalithera Bioscience...+0.35+6.21%
TRILTrillium Therapeutic...-0.82-5.31%
Data as of 09/03/2015

Financials

Next reporting dateSeptember 28, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
President &
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts

Partner Offers